Atlas Trials

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Clinical trial NCT00089102 · TERMINATED

Trial details

NCT number
NCT00089102
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Cancer
Start date
2003-09-01
Primary completion
2009-07-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.